U.S. vaccine manufacturer Novavax received a $1.6 billion handout at the expense of the American taxpayer, and based on the amount of vaccines they ACTUALLY administered, they completely wasted our money.
The vaccine manufacturer was supposed to take those funds and deliver 100 million doses of the COVID jab, but with consumers massively rejecting vaccines altogether, the company reveals they have only administered a meager 7,300 shots in the U.S. to date.
In fact, the public’s refusal to take their vaccine has forced the company to slash expected sales for 2022 down to just $2 billion from the $5 billion they originally forecasted.
The company’s CEO, discussing the massive failure, blamed the fact that there are simply too many vaccines in circulation right now, and not enough people are willing to take the injections.
The company was also one of the last to bring their vaccine to market, despite taking the funding around the same time as its other competitors which rolled out their vaccines much sooner.
“I believe we were late to the market, and U.S. vaccination was driven by what was available and shown to work: mRNA vaccines,” said the company’s CEO, essentially excusing the fact that they wasted nearly $2 billion worth of tax-payer funds.
To find out what’s really going here and how this vaccine company may have STOLEN from the American taxpayer, watch the video here.